Mindfulness Meditation in Hemodialysis Patients

The Effect of Mindfulness Meditation on Sleep, Stress, and Symptoms in Hemodialysis Patients: A Randomized Controlled Trial

This randomised controlled study aims to evaluate the effects of mindfulness meditation on sleep quality, perceived stress and symptoms levels ion hemodialysis patients. Participants in the intervention group will receive a 4 week mindfulness meditation program in addition to routine care. Outcomes will be assessed before and after the intervention using validated measurement tools.

This study is designed as a randomized controlled experimental trial conducted in hemodialysis units in Northern Cyprus. Hemodialysis patients will be randomly assigned to intervention and control groups.The intervention group will participane in a structured 4 week mindfulness meditation program delivered through guided sessions, while the control group will continue receiving routine care. The study aims to determine the effectiveness of mindfulness meditation on sleep quality, stress levels and symptoms management in hemodialysis patients. Data will be collected before and after the intervention using validated assessment scales.

Inclusion Criteria:

• Patients aged between 18 and 75 years
• Patients receiving hemodialysis treatment for at least 3 months
• Patients with cognitive functions suitable for the intervention (dementia score ≥21)
• Patient without hearing, vision or communication problems
• Patients without a psychiatric diagnosis
• Patients able to use a smartphone or tablet
• Patients not participating in another study
• Patients not using sleep medication or antipsychotic drugs

Exclusion Criteria:

• Patients younger than 18 years or older than 75 years
• Patients receiving hemodialysis treatment for less than 3 months
• Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21)
• Patient with hearing, vision or communication disabilities
• Patients diagnosed with psychiatric disorders
• Patients unable to use a smartphone or tablet
• Patients participating in another study
• Patients using sleep medication or antipsychotic drugs